Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07446478
What this trial is testing

TIS for Improving Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Central South University 10
Not applicableStudy completedNCT03656770
What this trial is testing

Measuring Beliefs and Norms About Persons With Mental Illness

Who this might be right for
Mental IllnessSchizophreniaBipolar Disorder+1 more
Massachusetts General Hospital 1,782
Post-approval studies (Phase 4)Study completedNCT00628394
What this trial is testing

Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation

Who this might be right for
Cognition in Schizophrenia
University of Texas Southwestern Medical Center 119
Not applicableStudy completedNCT02131129
What this trial is testing

RTMS in First Episode Psychosis

Who this might be right for
SchizophreniaSchizophreniform DisorderSchizoaffective Disorder
Indiana University 20
Not applicableStudy completedNCT01373866
What this trial is testing

Multimodal MRI-guided rTMS to Treat Refractory Hallucinations

Who this might be right for
HallucinationsSchizophreniaPerceptual Disorders
University Hospital, Lille 85
Large-scale testing (Phase 3)Ended earlyNCT03121586
What this trial is testing

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

Who this might be right for
Schizophrenia
ACADIA Pharmaceuticals Inc. 995
Large-scale testing (Phase 3)Study completedNCT00113594
What this trial is testing

Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Eli Lilly and Company 100
Early research (Phase 1)Study completedNCT01634373
What this trial is testing

Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets

Who this might be right for
Schizophrenia
Torrent Pharmaceuticals Limited
Testing effectiveness (Phase 2)Study completedNCT01852331
What this trial is testing

Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizophrenic DisorderHyperprolactinemia+1 more
The University of Hong Kong 103
Large-scale testing (Phase 3)Study completedNCT01911429
What this trial is testing

Pediatric Schizophrenia Efficacy and Safety Study

Who this might be right for
Schizophrenia
Sumitomo Pharma America, Inc. 327
Not applicableUnknownNCT05933356
What this trial is testing

Effectiveness of Exergames on Cognitive, Social Functionamong Chronic Schizophrenia

Who this might be right for
Gambling
Kaohsiung Medical University Chung-Ho Memorial Hospital 154
Early research (Phase 1)Study completedNCT01696929
What this trial is testing

An Open-Label Trial of Tocilizumab in Schizophrenia

Who this might be right for
Schizophrenia
Brian Miller 8
Post-approval studies (Phase 4)Ended earlyNCT05741502
What this trial is testing

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

Who this might be right for
Treatment-resistant Schizophrenia
Ohio State University 5
Early research (Phase 1)Study completedNCT04787302
What this trial is testing

PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing

Who this might be right for
Schizophrenia
Cerevel Therapeutics, LLC 15
Large-scale testing (Phase 3)Study completedNCT01190254
What this trial is testing

Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)

Who this might be right for
Schizophrenia, ParanoidSchizophrenia, DisorganizedSchizophrenia, Undifferentiated
Organon and Co 306
Testing effectiveness (Phase 2)UnknownNCT02426983
What this trial is testing

Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination

Who this might be right for
Schizophrenia
University of Ottawa 12
Not applicableStudy completedNCT05445466
What this trial is testing

Causal Lesion Network Guided Treatment of Bipolar Mania With Transcranial Electrical Stimulation

Who this might be right for
Bipolar DisorderSchizo Affective Disorder
Beth Israel Deaconess Medical Center 14
Early research (Phase 1)Study completedNCT05342727
What this trial is testing

Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia

Who this might be right for
SchizophreniaCognitive Dysfunction
The National Brain Mapping Laboratory (NBML) 50
Not applicableStudy completedNCT00248794
What this trial is testing

Cognitive Rehabilitation in Schizophrenia

Who this might be right for
Cognitive ImpairmentSchizophrenia
VA Office of Research and Development 59
Post-approval studies (Phase 4)Study completedNCT02625103
What this trial is testing

The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.

Who this might be right for
Schizophrenia
Anders Fink-Jensen, MD, DMSci 48
Next Page